NMRA · ISSUER CIK 1885522
Neumora Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Neumora Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $702K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$702KInsider selling
−$702KNet open-market
Aug 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 202619:10 | Aug 21, 2026from Aug 20, 2026 | NMRA | See Remarks | S · Sell | $1.53 | −176,060 | 48,750 | -78% | −$270K | ||
| Aug 21, 202619:10 | Aug 21, 2026from Aug 20, 2026 | NMRA | See Remarks | M · Exercise | $0.72 | +176,060 | 69,303 | — | $127K | ||
| Aug 19, 202619:17 | Aug 19, 2026from Aug 17, 2026 | NMRA | See Remarks | S · Sell | $1.55 | −277,773 | 48,750 | -85% | −$432K | ||
| Aug 19, 202619:17 | Aug 19, 2026from Aug 17, 2026 | NMRA | See Remarks | M · Exercise | $0.72 | +243,753 | 79,750 | — | $176K |